Transurethral resection of the prostate in Northern Nigeria, problems and prospectsReportar como inadecuado

Transurethral resection of the prostate in Northern Nigeria, problems and prospects - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

BMC Urology

, 8:18

First Online: 06 December 2008Received: 07 January 2008Accepted: 06 December 2008


BackgroundBenign prostatic hyperplasia BPH is the commonest disease of the urinary tract afflicting the ageing male and is the commonest neoplastic disease in men aged 50 years and above.

Transurethral prostatectomy TURP is the ultimate treatment of choice for benign prostatic hyperplasia BPH due mainly to the preference of minimally invasive surgery, long term relief of symptoms and cost effectiveness. It is however not available to the majority of Nigerians in need of prostatic surgery in Public Health Institutions.

MethodsThe records of patients who underwent prostatectomy in Aminu Kano Teaching Hospital, over the period June 2001 to July 2007 were examined. The bio data of patients and laboratory investigations performed were retrieved.

ResultsFive Hundred and forty two patients were operated upon, out of which 40 were excluded due to open prostatectomy 22 patients, bladder neck stenosis 16 patients or bladder tumour around the trigon 2 patients. The age range of the patients was 47–110 years with a mean of 67.2 years. 289 patients 80.1% had urethral catheter in situ at presentation and 11 3% patients had suprapubic cystostomy of which only 3 0.85% had combined urethral stricture and BPH.

Only 131 26% had their PSA measured which ranged from 2–100 ng-ml out of which 3929.8% n = 131 patients had more than 4 ng-ml and cancer of the prostate and 10.8%, n = 131 patient had a PSA level of 4 ng-ml and malignant prostate.

Hospital stay was 1–32 days mean 7.9 and the mean follow up period was 5.6 months range 0–60 and there were 17.5% complications comprising of urinary tract infection UTI 7.2%, Orchitis 2.2%, urinary incontinence 0.6%, atonic bladder 1%, erectile dysfunction 0.6%, cerebrovascular accident 0.4%, myocardial infarction 0.4%, deep vein thrombosis 0.4% and disseminated intravascular coagulopathy DIC 0.6% and 1.2% mortality. The cost of treatment inclusive of pre-admission investigations was US$ 615.00 range US$ 300–1,300

ConclusionDespite advances in minimally invasive therapy for LUTH-BPH, TURP is the optimum treatment of choice for the ageing male of sub-Saharan Africa. It is however not available to the majority of patients in this region due to poor health allocation and inadequate facilities and training.

Electronic supplementary materialThe online version of this article doi:10.1186-1471-2490-8-18 contains supplementary material, which is available to authorized users.

SU Alhasan, SA Aji, AZ Mohammed and S Malami contributed equally to this work.

Download fulltext PDF

Autor: SU Alhasan - SA Aji - AZ Mohammed - S Malami


Documentos relacionados